What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Gene
The scientist’s investigation covers issues in Internal medicine, Cirrhosis, Gastroenterology, Hepatitis C virus and Immunology.
His Internal medicine research is multidisciplinary, relying on both Ribavirin and Surgery.
His Cirrhosis research includes elements of Liver transplantation, Ascites and Pathology.
Within one scientific family, Rafael Esteban focuses on topics pertaining to Randomized controlled trial under Gastroenterology, and may sometimes address concerns connected to Post-exposure prophylaxis and Protein catabolism.
His study on Hepatitis C virus is covered under Virology.
His Immunology study integrates concerns from other disciplines, such as Hepatitis E and Hepatitis E virus.
His most cited work include:
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B (1528 citations)
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection (1435 citations)
- Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. (861 citations)
What are the main themes of his work throughout his whole career to date?
Rafael Esteban focuses on Internal medicine, Virology, Gastroenterology, Immunology and Hepatitis C virus.
His Internal medicine study combines topics from a wide range of disciplines, such as Chronic hepatitis and Ribavirin.
His research ties Genotype and Virology together.
His Gastroenterology research incorporates elements of Boceprevir and Surgery.
His work on Hepacivirus and Flaviviridae as part of general Hepatitis C virus research is frequently linked to Subtyping, thereby connecting diverse disciplines of science.
His research investigates the link between Hepatitis B virus and topics such as Hepatitis B that cross with problems in Entecavir.
He most often published in these fields:
- Internal medicine (55.63%)
- Virology (44.37%)
- Gastroenterology (35.36%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (55.63%)
- Gastroenterology (35.36%)
- Virology (44.37%)
In recent papers he was focusing on the following fields of study:
Rafael Esteban mainly focuses on Internal medicine, Gastroenterology, Virology, Hepatitis C virus and Hepatitis B.
His Internal medicine research is multidisciplinary, relying on both Entecavir and HBsAg.
His work deals with themes such as Liver transplantation, Hepatitis C, Adverse effect and Cohort, which intersect with Gastroenterology.
His study looks at the relationship between Virology and topics such as Genotype, which overlap with Virus.
Rafael Esteban mostly deals with Ribavirin in his studies of Hepatitis C virus.
His Hepatitis B study combines topics in areas such as Viral replication and Rituximab.
Between 2016 and 2021, his most popular works were:
- The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. (138 citations)
- Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study. (62 citations)
- Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Gene
Internal medicine, Gastroenterology, Hepatitis B, Entecavir and Hepatitis C virus are his primary areas of study.
The study incorporates disciplines such as Surgery and Sofosbuvir in addition to Internal medicine.
His Gastroenterology research incorporates themes from Hepatitis C and Randomized controlled trial.
The Hepatitis B study combines topics in areas such as HBsAg and Hepatitis B virus.
His Entecavir research focuses on Hepatocellular carcinoma and how it relates to Cohort and Hepatology.
His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Chronic liver disease, Drug resistance and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
